NCT03357315View on ClinicalTrials.gov

Mix Vaccine for Metastatic Sarcoma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

August 30, 2019

Conditions
Metastatic SarcomaReaction - Mixed Vaccine
Interventions
BIOLOGICAL

Mix vaccine

Each treatment: 0.5 ml /week, Subcutaneous injection of the deltoid muscle

Trial Locations (1)

510665

Fuda cancer institute of Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Jinan University Guangzhou

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT03357315 - Mix Vaccine for Metastatic Sarcoma Patients | Biotech Hunter | Biotech Hunter